Coxib-inhibition of Duodenal Polyp Growth in Familial Adenomatous Polyposis
Phase 2/Phase 3
18 Years
70 Years
18 Years
70 Years
Not Enrolling
Both
Duodenal Polyposis
Both
Duodenal Polyposis
Trial Information
Coxib-inhibition of Duodenal Polyp Growth in Familial Adenomatous Polyposis
Inclusion Criteria:
- FAP patient with previous colectomy and confirmed polyposis
Exclusion Criteria:
- Pregnancy
- Malignancy
- NSAID hypersensitivity
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Authority:
Norway:National Committee for Medical and Health Research Ethics
Study ID:
RH01/01
NCT ID:
NCT00844727
Start Date:
September 2003
Completion Date:
April 2004
Related Keywords:
- Duodenal Polyposis
- Adenomatous Polyposis Coli
Name | Location |
|---|
